Aksia Group SGR SpA announces the acquisition - through the portfolio company COC Farmaceutici - of Tubilux Pharma, one of the top Italian players active in the research, development and manufacturing of pharmaceutical ophthalmic products for blue-chip international pharmaceutical companies. PRESS RELEASE
Aksia Group SGR SpA announces the acquisition of the 65% of VOMM Impianti e Processi, a well-established player active in the engineering and production of plants for continuous industrial processes in the environmental, pharma-chemical and agri-food sectors. This transaction represents the third investment for Aksìa Capital V. PRESS RELEASE
Aksìa Capital IV, completed the sale of a majority stake in Alpha Test, leading player in university admission and other tests preparation services, to White Bridge Investments II realizing an IRR for the transaction in excess of 36% equal to approximately three times the initial investment. PRESS RELEASE
Aksia Group SGR SpA announces the acquisition of a relevant majority stake of Valpizza, a well-established player active in the production and commercialization of frozen pizza. This is the second investment of Aksìa Capital V fund after the leader in dental clinics and polyclinics market, Primo Group. PRESS RELEASE
A donation of €100 thousand has been put in place to support Italian Health System. PRESS RELEASE
Our commitment to deliver the best value added and our resilient capabilities remain intact to achieve our goals. Compliant with best HSE requirements we bring Italy forward. Ready to make our best.
At beginning of 2020 Aksìa Group has further strengthened the Investment Team through the hiring of Edoardo Peroglio Longhin as Investment Manager and Guglielmo Orsatti as Senior Analyst.
Edoardo Peroglio Longhin: graduated from School of Management and Economics of Turin, he has a consolidated background in deals and M&A acquired in more than five year in Transaction Service of EY where he was engaged in Retail, Consumer e Private Equity industries;
Guglielmo Orsatti: graduated from Bocconi University of Milano, he worked in the Italian office of the French private equity PAI Partners for about two years, after some experiences in Investment Banking (Rothschild and Mediobanca).
From the combination of the entities will be created the second player on Italian market. PRESS RELEASE
Covisian Group through its Spain subsidiary GSS, acquires Avanza's Group business lines dedicated to customer management. PRESS RELEASE
Aksìa Group SGR with the fund Aksìa Capital V invests in the healthcare sector by acquiring Primo Group and Oasi Medica, leading players in the dental clinics and polyclinics market. PRESS RELEASE
Casa Della Piada (CRM), protfolio company of Aksìa Capital IV, expands its product range by acquiring Gastone, leading palyer in the production and commercialization of PGI Piadina. PRESS RELEASE
Aksìa is glad to announce that on 1st July 2019, Aksìa Capital IV completed the sale of 100% of Lameplast S.p.A. to the global group Tekni-Plex Inc. for an Enterprise Value of Euro 88 million realizing an IRR for the transaction in excess of 60%. PRESS RELEASE
Aksìa Capital III, managed by Aksìa Group SGR, completed the sale of its last portfolio company MEP Group to Groupe Legris Industries, a European diversified industrial group. PRESS RELEASE
On January 26th, 2019, Covisian, the Italian leader in business process outsourcing services and innovative customer care solutions, investee company of Aksìa Capital IV, acquired the Spanish group Global Sales Solutions (GSS), specialized in customer management services, leader in Spain and Latin America, high growth regions for the BPO sector. PRESS RELEASE
At the beginning of 2019, Aksìa Group has officially launched the fund raising of the new fund Aksìa Capital V. The target is € 200 million to continue in its consolidated investment strategy on the Italian mid-market.
At the beginning of 2019, the two Investment Directors of Aksìa Group Marco Albanesi and Sara Perillo have been nominated Partners. Marco and Sara, who joined the team in June 2010 and July 2013 respectively, have 10+ years of experience on the Italian mid-market and will be actively involved in the fundraising and management of Aksìa Capital V with the Managing Partners and Founders Nicola Emanuele e Marco Rayneri.
On December 5th, 2018, Aksìa Group held its Annual General Meeting in Milan at the Covisian (investee company of Aksìa Capital IV) headquarter. The event, like every year, aims at illustrate to LPs and the Italian financial community, the performance of the funds managed by Aksìa Group, forecasts for the new year and future strategies.
Lameplast SpA, European leader in primary packaging for pharmaceuticals, investee company of Aksìa Capital IV, has launched a strategic partnership in the US with National Moulding for the production on the US territory, with its proprietary technology. Lameplast already has important customers overseas and envisages a further growth in the next three years.